-+ 0.00%
-+ 0.00%
-+ 0.00%

*Processa Pharma: FDA Clears IND for Phase 2 Study of VT-7208 in Chronic Spontaneous Urticaria >PCSA

Dow Jones·10/29/2026 12:10:27